Chronic obstructive pulmonary disease: a complex comorbidity of lung cancer

Article OPEN
Grose, Derek ; Milroy, Robert (2011)
  • Publisher: Swiss Medical Press GmbH
  • Journal: volume 1, pages 45-50 (issn: 2235-042X, eissn: 2235-042X)
  • Related identifiers: pmc: PMC5556420, doi: 10.15256/joc.2011.1.5
  • Subject: chronic obstructive pulmonary disease (COPD) | lung cancer | R | comorbidity | inflammation | Review | pulmonary | Medicine | oxidative stress
    mesheuropmc: respiratory system | respiratory tract diseases

Chronic obstructive pulmonary disease (COPD) is a major burden throughout the world. It is associated with a significantly increased incidence of lung cancer and may influence treatment options and outcome. Impaired lung function confirming COPD is an independent risk factor for lung cancer. Oxidative stress and inflammation may be a key link between COPD and lung cancer, with numerous molecular markers being analysed to attempt to understand the pathway of lung cancer development. COPD negatively influences the ability to deliver radical treatment options, so attempts must be made to look for alternative methods of treating lung cancer, while aiming to manage the underlying COPD. Detailed assessment and management plans utilising the multidisciplinary team must be made for all lung cancer patients with COPD to provide the best care possible. Journal of Comorbidity 2011;1:45–50
Share - Bookmark